China National Medicines Corp Ltd Cash Flow Reinvestment Rate
China National Medicines Corp Ltd cash flow reinvestment rate. China National Medicines Corp Ltd (600511) has a Cash Flow Reinvestment Rate of 0.11x as of June 2025, reinvesting CN¥42.55 Million (capex CN¥13.23 Million plus investments CN¥29.33 Million) from operating cash flow of CN¥382.74 Million. Explore China National Medicines Corp Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of China National Medicines Corp Ltd (2002–2024)
Cash flow reinvestment rate of China National Medicines Corp Ltd from 2002 to 2024. Historical reinvestment intensity for China National Medicines Corp Ltd across 22 annual periods. Explore reinvestment intensity of China National Medicines Corp Ltd to see what proportion of operating cash flow is directed to capital expenditures.
China National Medicines Corp Ltd Cash Flow Reinvestment Rate by Year (2002–2024)
China National Medicines Corp Ltd cash flow reinvestment rate by year from 2002 to 2024. Year-by-year capital reinvestment analysis for China National Medicines Corp Ltd. For the full cash flow conversion analysis, see how efficiently does China National Medicines Corp Ltd generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥177.45 Million | CN¥1.66 Billion | CN¥130.77 Million | ▲ +6.3% |
| 2023 | 0.10x | CN¥274.44 Million | CN¥2.73 Billion | CN¥145.12 Million | ▼ -14.5% |
| 2022 | 0.12x | CN¥282.10 Million | CN¥2.40 Billion | CN¥129.78 Million | ▲ +108.0% |
| 2021 | 0.06x | CN¥110.82 Million | CN¥1.96 Billion | CN¥95.07 Million | ▲ +2.5% |
| 2020 | 0.06x | CN¥71.92 Million | CN¥1.30 Billion | CN¥69.05 Million | ▲ +13.3% |
| 2019 | 0.05x | CN¥86.62 Million | CN¥1.78 Billion | CN¥85.72 Million | ▼ -75.2% |
| 2018 | 0.20x | CN¥192.66 Million | CN¥981.65 Million | CN¥132.46 Million | ▲ +79.3% |
| 2017 | 0.11x | CN¥117.63 Million | CN¥1.07 Billion | CN¥73.25 Million | ▼ -20.3% |
| 2016 | 0.14x | CN¥81.25 Million | CN¥591.25 Million | CN¥39.88 Million | ▼ -11.8% |
| 2015 | 0.16x | CN¥68.62 Million | CN¥440.29 Million | CN¥68.47 Million | ▼ -77.0% |
| 2014 | 0.68x | CN¥148.22 Million | CN¥218.94 Million | CN¥148.22 Million | ▲ +3.3% |
| 2013 | 0.66x | CN¥121.66 Million | CN¥185.56 Million | CN¥121.66 Million | ▼ -28.2% |
| 2012 | 0.91x | CN¥169.65 Million | CN¥185.87 Million | CN¥169.65 Million | ▲ +1105.7% |
| 2010 | 0.08x | CN¥24.09 Million | CN¥318.21 Million | CN¥24.09 Million | ▼ -13.5% |
| 2009 | 0.09x | CN¥22.33 Million | CN¥255.18 Million | CN¥22.33 Million | ▲ +17.2% |
| 2008 | 0.07x | CN¥16.21 Million | CN¥217.10 Million | CN¥16.21 Million | ▼ -31.1% |
| 2007 | 0.11x | CN¥8.61 Million | CN¥79.48 Million | CN¥8.61 Million | ▼ -44.7% |
| 2006 | 0.20x | CN¥23.81 Million | CN¥121.50 Million | CN¥23.81 Million | ▼ -56.2% |
| 2005 | 0.45x | CN¥41.24 Million | CN¥92.20 Million | CN¥41.24 Million | ▼ -74.7% |
| 2004 | 1.77x | CN¥87.08 Million | CN¥49.18 Million | CN¥87.08 Million | ▼ -99.0% |
| 2003 | 172.79x | CN¥90.92 Million | CN¥526.15K | CN¥90.92 Million | ▲ +18401.7% |
| 2002 | 0.93x | CN¥14.19 Million | CN¥15.19 Million | CN¥14.19 Million | — |